483 Intas Pharmaceuticals May 2017

483 Intas Pharmaceuticals May 2017

Patric Klotzbuecher FDA, Bijoy Panicker FDA, Daniel Roberts FDA$119.00 - Available Now

FDA investigators audited the Intas Pharmaceuticals - Moraiya, India facility and issued 14 inspectional observations (via FDA 483) on 10 May 2017.

Product details

  • Category: Human Drugs
  • Number of Observations: 14
  • Inspection end: 10 May 2017
  • Location: Moraiya, India
  • FEI: 3007277149
Add To Cart